Annual CFI
-$53.65 M
-$48.24 M-892.89%
31 December 2023
Summary:
Inozyme Pharma annual cash flow from investing activities is currently -$53.65 million, with the most recent change of -$48.24 million (-892.89%) on 31 December 2023. During the last 3 years, it has risen by +$63.53 million (+54.22%). INZY annual CFI is now -225.35% below its all-time high of $42.80 million, reached on 31 December 2021.INZY Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$23.35 M
+$5.53 M+31.05%
30 September 2024
Summary:
Inozyme Pharma quarterly cash flow from investing activities is currently $23.35 million, with the most recent change of +$5.53 million (+31.05%) on 30 September 2024. Over the past year, it has increased by +$67.96 million (+152.33%). INZY quarterly CFI is now at all-time high.INZY Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$45.09 M
+$67.96 M+297.11%
30 September 2024
Summary:
Inozyme Pharma TTM cash flow from investing activities is currently $45.09 million, with the most recent change of +$67.96 million (+297.11%) on 30 September 2024. Over the past year, it has increased by +$89.05 million (+202.57%). INZY TTM CFI is now -30.40% below its all-time high of $64.78 million, reached on 31 March 2022.INZY TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -892.9% | +152.3% | +202.6% |
| 3 y3 years | +54.2% | +78.8% | +237.7% |
| 5 y5 years | -695.7% | +2589.9% | +1757.0% |
INZY Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -225.3% | +54.2% | at high | +152.3% | -30.4% | +179.1% |
| 5 y | 5 years | -225.3% | +54.2% | at high | +123.4% | -30.4% | +138.5% |
| alltime | all time | -225.3% | +54.2% | at high | +123.4% | -30.4% | +138.5% |
Inozyme Pharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $23.35 M(+31.1%) | $45.09 M(-297.1%) |
| June 2024 | - | $17.82 M(+71.4%) | -$22.88 M(-59.9%) |
| Mar 2024 | - | $10.39 M(-260.6%) | -$57.02 M(+6.3%) |
| Dec 2023 | -$53.65 M(+892.9%) | -$6.47 M(-85.5%) | -$53.65 M(+22.0%) |
| Sept 2023 | - | -$44.62 M(+173.3%) | -$43.96 M(+478.4%) |
| June 2023 | - | -$16.33 M(-218.6%) | -$7.60 M(-46.5%) |
| Mar 2023 | - | $13.77 M(+327.8%) | -$14.20 M(+162.8%) |
| Dec 2022 | -$5.40 M(-112.6%) | $3.22 M(-139.0%) | -$5.40 M(-723.9%) |
| Sept 2022 | - | -$8.26 M(-64.0%) | $866.00 K(-96.1%) |
| June 2022 | - | -$22.93 M(-201.6%) | $22.18 M(-65.8%) |
| Mar 2022 | - | $22.56 M(+137.8%) | $64.78 M(+51.4%) |
| Dec 2021 | $42.80 M | $9.49 M(-27.4%) | $42.80 M(+220.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $13.06 M(-33.6%) | $13.35 M(-113.4%) |
| June 2021 | - | $19.67 M(+3333.5%) | -$99.38 M(-12.2%) |
| Mar 2021 | - | $573.00 K(-102.9%) | -$113.20 M(-3.4%) |
| Dec 2020 | -$117.18 M(+1296.5%) | -$19.96 M(-80.0%) | -$117.18 M(+13.9%) |
| Sept 2020 | - | -$99.67 M(-1803.1%) | -$102.89 M(+4263.5%) |
| June 2020 | - | $5.85 M(-271.7%) | -$2.36 M(-82.6%) |
| Mar 2020 | - | -$3.41 M(-39.9%) | -$13.56 M(+61.6%) |
| Dec 2019 | -$8.39 M(-193.2%) | -$5.67 M(-753.2%) | -$8.39 M(+208.4%) |
| Sept 2019 | - | $868.00 K(-116.2%) | -$2.72 M(-24.2%) |
| June 2019 | - | -$5.35 M(-404.2%) | -$3.59 M(-304.2%) |
| Mar 2019 | - | $1.76 M | $1.76 M |
| Dec 2018 | $9.01 M | - | - |
FAQ
- What is Inozyme Pharma annual cash flow from investing activities?
- What is the all time high annual CFI for Inozyme Pharma?
- What is Inozyme Pharma annual CFI year-on-year change?
- What is Inozyme Pharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Inozyme Pharma?
- What is Inozyme Pharma quarterly CFI year-on-year change?
- What is Inozyme Pharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Inozyme Pharma?
- What is Inozyme Pharma TTM CFI year-on-year change?
What is Inozyme Pharma annual cash flow from investing activities?
The current annual CFI of INZY is -$53.65 M
What is the all time high annual CFI for Inozyme Pharma?
Inozyme Pharma all-time high annual cash flow from investing activities is $42.80 M
What is Inozyme Pharma annual CFI year-on-year change?
Over the past year, INZY annual cash flow from investing activities has changed by -$48.24 M (-892.89%)
What is Inozyme Pharma quarterly cash flow from investing activities?
The current quarterly CFI of INZY is $23.35 M
What is the all time high quarterly CFI for Inozyme Pharma?
Inozyme Pharma all-time high quarterly cash flow from investing activities is $23.35 M
What is Inozyme Pharma quarterly CFI year-on-year change?
Over the past year, INZY quarterly cash flow from investing activities has changed by +$67.96 M (+152.33%)
What is Inozyme Pharma TTM cash flow from investing activities?
The current TTM CFI of INZY is $45.09 M
What is the all time high TTM CFI for Inozyme Pharma?
Inozyme Pharma all-time high TTM cash flow from investing activities is $64.78 M
What is Inozyme Pharma TTM CFI year-on-year change?
Over the past year, INZY TTM cash flow from investing activities has changed by +$89.05 M (+202.57%)